Vaxart urges shareholder vote ahead of July proxy contest
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
Vaxart Publishes Presentation Urging Shareholders to Vote “FOR” ALL Six of the Company’s Highly Qualified Director Nominees on the WHITE Proxy Card TODAY
June 26, 2026 8:00 AM EDTDetails Strategic Actions Taken by the Board to Advance the Companys Pipeline and Drive Value Creation
Vaxarts Purpose-Built Board Brings the Proven Expertise Needed to Oversee its Next Phase of Growth
Dissident Nominees Lack Relevant Clinical-Stage Biotech Expertise, Misrepresented Their Qualifications
and Offered No Credible Ideas for Value Creation
Vaxart Has Made Multiple Settlement Offers to the Dissident Shareholder Group Daniel Houle Insists on Making This Proxy Contest About Winning a Seat for Himself
Visit... More
